Programmed cell death 1 (PD-1) is widely expressed in tumor-infiltrating lymphocytes in triple-negative breast cancer, and cell-surface PD-1 transduces negative signals for effector T cell activity during cell-cell contact (307). Here, PDCD1 is linked to neoplasm.